GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » FutureChem Co Ltd (XKRX:220100) » Definitions » Price-to-Owner-Earnings

FutureChem Co (XKRX:220100) Price-to-Owner-Earnings : (As of Jun. 01, 2025)


View and export this data going back to 2015. Start your Free Trial

What is FutureChem Co Price-to-Owner-Earnings?

As of today (2025-06-01), FutureChem Co's share price is ₩17290.00. FutureChem Co does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for FutureChem Co's Price-to-Owner-Earnings or its related term are showing as below:


XKRX:220100's Price-to-Owner-Earnings is not ranked *
in the Drug Manufacturers industry.
Industry Median: 25.175
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2025-06-01), FutureChem Co's share price is ₩17290.00. FutureChem Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-452.00. Therefore, FutureChem Co's PE Ratio (TTM) for today is At Loss.

As of today (2025-06-01), FutureChem Co's share price is ₩17290.00. FutureChem Co's EPS without NRI for the trailing twelve months (TTM) ended in was ₩-408.83. Therefore, FutureChem Co's PE Ratio without NRI for today is At Loss.


FutureChem Co Price-to-Owner-Earnings Historical Data

The historical data trend for FutureChem Co's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FutureChem Co Price-to-Owner-Earnings Chart

FutureChem Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

FutureChem Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of FutureChem Co's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, FutureChem Co's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


FutureChem Co's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, FutureChem Co's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where FutureChem Co's Price-to-Owner-Earnings falls into.


;
;

FutureChem Co Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

FutureChem Co's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=17290.00/-313.05
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


FutureChem Co  (XKRX:220100) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


FutureChem Co Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of FutureChem Co's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


FutureChem Co Business Description

Traded in Other Exchanges
N/A
Address
2Floor, 21, Yeonmujang 3-gil, Seongdong-gu, Seoul, KOR, 04782
FutureChem Co Ltd is a radiopharmaceuticals company engaged in manufacturing related precursors chemicals, automatic synthesizer, and synthesis reagents and develops & commercializes new traces with research and development. It offers radiopharmaceuticals for diagnosing cancers, and Alzheimer's diseases; and automation modules and disposable goods, such as disposable cassettes, reagent kits, and radio-caps. It also provides peptide-based radiopharmaceuticals for radio-metal chelation and click reaction; linkers for bio-conjugation using copper-free/mediated click reaction. In addition, the company is involved in the research and development of radioisotope labeling technology; and automation devices. Further, it offers amino acids and reagents for peptides; and ionic liquids.

FutureChem Co Headlines

No Headlines